Off-label drugs contribute to adverse drug events in adults, study finds Valeant sends letter in an attempt to reassure U.S. health care professionalsCompany offers reassurance patients will continue to have access to medicines. Catastrophic pharmacare is a catastrophe Why the provinces don’t need $3 billion in federal tax dollars for flawed prescription drug policies. Saskatoon children with rare disease to have costly drug covered by province Government to cover unproven drug for siblings with rare, deadly blood disease. Health authority releases new guidelines to treat opioid addictions in B.C. Doctors encouraged to rethink prescribing methadone for people battling opioid addictions. Saskatoon pharmacist ordered to pay $17,000 for changing doctor’s orders But Ian Delmage maintains he did nothing wrong and that the college's decision undermines the profession. Going off-label fraught with hazards Quebec study links off-label prescribing with adverse drug events Alberta to make antidote to fentanyl overdoses available at more places Naloxone could soon be available at universities, pharmacies and doctors' offices. Canada’s Valeant faces intense pressure in U.S. Drug pricing scandal in States puts our RX darling under the microscope. Playing the long game Building our reputation takes patience and patient care. First Previous 700 701 702 703 704 Next Last
